VIMTA LABS
Back to Cashflow Statement
|
VIMTA LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.90 Cr | ₹-11 Cr | ₹-17 Cr | ₹-4.57 Cr | ₹-0.67 Cr |
What is the latest Cash Flow from Financing Activities ratio of VIMTA LABS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1.90 Cr |
Mar2023 | ₹-11 Cr |
Mar2022 | ₹-17 Cr |
Mar2021 | ₹-4.57 Cr |
Mar2020 | ₹-0.67 Cr |
How is Cash Flow from Financing Activities of VIMTA LABS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1.90 Cr | Negative | |
Mar2023 | ₹-11 Cr | Negative | |
Mar2022 | ₹-17 Cr | Negative | |
Mar2021 | ₹-4.57 Cr | Negative | |
Mar2020 | ₹-0.67 Cr | - |
Compare Cash Flow from Financing Activities of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,054.4 Cr | -7.5% | 5.3% | 136.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | -7.5% |
5.3% |
136.8% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses